FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly oncology, and can be used for treating patients with skin toxicity. Method involves therapeutic plasmapheresis accompanying development of skin toxicity of degree 2-3 within 24 hours before and 24 hours after administration of the EGFR inhibitor; if necessary, the procedure is repeated.
EFFECT: use of the invention enables reducing manifestations of skin toxic reactions, improving quality of life of patients, enables continuing treatment with targeted preparations, observing the interval of administration.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| THERAPEUTIC USE OF MEDICINAL FORMS OF BERBERINE | 2016 |
|
RU2733743C2 |
| HERBAL EXTRACT OF HEMP WITH LOW CONTENT OF TETRAHYDROCANNABINOL (THC) FOR TREATMENT OF DISEASES | 2008 |
|
RU2599028C2 |
| WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
| METHOD OF TREATING PATIENTS WITH PSORIASIS | 2009 |
|
RU2411049C1 |
| ANTI-INFLAMMATORY AND ANTI-ITCHING CREAM FOR TREATMENT OF DERMATOLOGICAL DISEASE | 2002 |
|
RU2233152C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
| METHOD FOR EVALUATING THE EFFICIENCY OF TREATING DERMATOLOGICAL DISEASES | 2006 |
|
RU2317004C2 |
| OINTMENT FOR TREATING PSORIASIS (VERSIONS) | 2018 |
|
RU2705162C1 |
| METHOD OF THERAPEUTIC DISCRETE PLASMAPHERESIS WITH EXTRACORPOREAL ERYTHROXYTE AND LEUKOCYTE MODIFICATION WITH INTERFERON INDUCERS, ANTIOXIDANTS AND CELL PROTECTORS | 2012 |
|
RU2489172C1 |
